Search Results

Filter
  • 1-10 of  40,473 results for ""Neprilysin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Valproate Administration to Adult 5xFAD Mice Upregulates Expression of Neprilysin and Improves Olfaction and Memory.

  • Authors : Vasilev DS; Institute of Evolutionary Physiology and Biochemistry RAS, 44 Thorez Avenue, Saint Petersburg, 194223, Russia. .; Dubrovskaya NM

Subjects: Neprilysin*/Neprilysin*/Neprilysin*/genetics ; Neprilysin*/Neprilysin*/Neprilysin*/metabolism ; Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology

  • Source: Journal of molecular neuroscience : MN [J Mol Neurosci] 2024 Nov 16; Vol. 74 (4), pp. 110. Date of Electronic Publication: 2024 Nov 16.Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease.

  • Authors : Thakur S; Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani Campus, Vidya Vihar, Pilani, 333031, (RJ), India.; Mohanty P

Subjects: Neprilysin*/Neprilysin*/Neprilysin*/antagonists & inhibitors ; Neprilysin*/Neprilysin*/Neprilysin*/metabolism; Humans

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Dec 15; Vol. 280, pp. 116932. Date of Electronic Publication: 2024 Oct 04.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry.

  • Authors : Stolfo D; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and Univeristy Hospital of Trieste, Trieste, Italy.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology ; Stroke Volume*/Stroke Volume*/Stroke Volume*/physiology

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Oct; Vol. 26 (10), pp. 2243-2257. Date of Electronic Publication: 2024 Jul 30.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844

Record details

×
Academic Journal

The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study.

  • Authors : Wang Y; Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.; Zhou C

Subjects: Peritoneal Dialysis* ; Valsartan*/Valsartan*/Valsartan*/therapeutic use ; Neprilysin*/Neprilysin*/Neprilysin*/antagonists & inhibitors

  • Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (2), pp. 2431637. Date of Electronic Publication: 2024 Nov 28.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction.

  • Authors : Stegmann T; Department of Cardiology, Leipzig University Hospital, Leipzig, Germany.; Parentin L

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology ; Valsartan*/Valsartan*/Valsartan*/therapeutic use

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Dec 01; Vol. 327 (6), pp. H1477-H1489. Date of Electronic Publication: 2024 Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial.

  • Authors : Tanaka A; Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.; Kida K

Subjects: Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/therapeutic use ; Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/therapeutic use ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/therapeutic use

  • Source: European heart journal [Eur Heart J] 2024 Nov 08; Vol. 45 (42), pp. 4482-4493.Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting Intestinal Neprilysin to Ameliorate Glucose Homeostasis Through Insulinotropic Effect.

  • Authors : Mizuma S; Graduate School of Agriculture, Hokkaido University, Sapporo 060-8589, Japan.; Hira T

Subjects: Homeostasis* ; Neprilysin*/Neprilysin*/Neprilysin*/metabolism ; Neprilysin*/Neprilysin*/Neprilysin*/antagonists & inhibitors

  • Source: Endocrinology [Endocrinology] 2024 Sep 26; Vol. 165 (11).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sacubitril/valsartan alleviates sepsis-induced myocardial injury in rats via dual angiotensin receptor-neprilysin inhibition and modulation of inflammasome/caspase 1/IL1β pathway.

  • Authors : Refaie MMM; Department of Medical Pharmacology, Faculty of Medicine, Minia University, 61511, El-Minia, Egypt. Electronic address: .; El-Hussieny M

Subjects: Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/pharmacology ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/therapeutic use ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/pharmacology

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Sep 15; Vol. 979, pp. 176834. Date of Electronic Publication: 2024 Jul 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass.

  • Authors : Hoshino J; Department of Cardiac and Vascular Surgery, Dokkyo Medical University.; Department of Cardiovascular Surgery, Gunma Prefectural Cardiovascular Center.

Subjects: Neprilysin*/Neprilysin*/Neprilysin*/antagonists & inhibitors ; Neprilysin*/Neprilysin*/Neprilysin*/blood ; Valsartan*

  • Source: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2024 Aug 23; Vol. 88 (9), pp. 1406-1415. Date of Electronic Publication: 2024 Apr 24.Publisher: Japanese Circulation Society Country of Publication: Japan NLM ID: 101137683 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  40,473 results for ""Neprilysin""